# Equifax Inc: financial statements, quarterly

EFX · NYSE · CIK 33185 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/efx.md) · [Financials](/companies/efx/financials.md) · [Filings](/companies/efx/filings.md) · [Insiders](/companies/efx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/efx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,327 d](/filings/0000033185-26-000010.md) | [1,389](/filings/0000033185-25-000042.md) | [1,431](/filings/0000033185-25-000054.md) | [1,442](/filings/0000033185-25-000064.md) | [1,419 d](/filings/0000033185-26-000010.md) | [1,442](/filings/0000033185-26-000018.md) | [1,537](/filings/0000033185-26-000028.md) | [1,545](/filings/0000033185-26-000044.md) | [1,551 d](/filings/0000033185-26-000010.md) | [1,649](/filings/0000033185-26-000018.md) | [1,700](/filings/0000033185-26-000028.md) | [1,693](/filings/0000033185-26-000044.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [343 d](/filings/0000033185-26-000010.md) | [373](/filings/0000033185-25-000042.md) | [353](/filings/0000033185-25-000054.md) | [380](/filings/0000033185-25-000064.md) | [345 d](/filings/0000033185-26-000010.md) | [375](/filings/0000033185-26-000018.md) | [384](/filings/0000033185-26-000028.md) | [434](/filings/0000033185-26-000044.md) | [421 d](/filings/0000033185-26-000010.md) | [411](/filings/0000033185-26-000018.md) | [423](/filings/0000033185-26-000028.md) | [390](/filings/0000033185-26-000044.md) |
| Operating income | $m | [245 d](/filings/0000033185-26-000010.md) | [225](/filings/0000033185-25-000042.md) | [282](/filings/0000033185-25-000054.md) | [247](/filings/0000033185-25-000064.md) | [288 d](/filings/0000033185-26-000010.md) | [236](/filings/0000033185-26-000018.md) | [311](/filings/0000033185-26-000028.md) | [264](/filings/0000033185-26-000044.md) | [284 d](/filings/0000033185-26-000010.md) | [288](/filings/0000033185-26-000018.md) | [314](/filings/0000033185-26-000028.md) | [355](/filings/0000033185-26-000044.md) |
| Interest expense | $m | [60.3 d](/filings/0000033185-24-000017.md) | [59.7](/filings/0000033185-24-000032.md) | [57.3](/filings/0000033185-25-000054.md) | [56.3](/filings/0000033185-25-000064.md) | [55.7 d](/filings/0000033185-26-000010.md) | [52.9](/filings/0000033185-26-000018.md) | [53.1](/filings/0000033185-26-000028.md) | [52.2](/filings/0000033185-26-000044.md) | [54.1 d](/filings/0000033185-26-000010.md) | [55.7](/filings/0000033185-26-000018.md) | [59.8](/filings/0000033185-26-000028.md) | [62.3](/filings/0000033185-26-000044.md) |
| Income tax | $m | [48.3 d](/filings/0000033185-26-000010.md) | [40.5](/filings/0000033185-25-000042.md) | [59.4](/filings/0000033185-25-000054.md) | [51.1](/filings/0000033185-25-000064.md) | [52.2 d](/filings/0000033185-26-000010.md) | [51.6](/filings/0000033185-26-000018.md) | [68.7](/filings/0000033185-26-000028.md) | [53.8](/filings/0000033185-26-000044.md) | [56.5 d](/filings/0000033185-26-000010.md) | [62.5](/filings/0000033185-26-000018.md) | [71.8](/filings/0000033185-26-000028.md) | [83.4](/filings/0000033185-26-000044.md) |
| Net income | $m | [132 d](/filings/0000033185-26-000010.md) | [125](/filings/0000033185-25-000042.md) | [164](/filings/0000033185-25-000054.md) | [141](/filings/0000033185-25-000064.md) | [174 d](/filings/0000033185-26-000010.md) | [133](/filings/0000033185-26-000018.md) | [191](/filings/0000033185-26-000028.md) | [160](/filings/0000033185-26-000044.md) | [176 d](/filings/0000033185-26-000010.md) | [172](/filings/0000033185-26-000018.md) | [184](/filings/0000033185-26-000028.md) | [212](/filings/0000033185-26-000044.md) |
| Diluted EPS | $ per share | not reported | [1.00](/filings/0000033185-25-000042.md) | [1.31](/filings/0000033185-25-000054.md) | [1.13](/filings/0000033185-25-000064.md) | not reported | [1.06](/filings/0000033185-26-000018.md) | [1.53](/filings/0000033185-26-000028.md) | [1.29](/filings/0000033185-26-000044.md) | not reported | [1.42](/filings/0000033185-26-000018.md) | [1.54](/filings/0000033185-26-000028.md) | [1.79](/filings/0000033185-26-000044.md) |
| Basic EPS | $ per share | not reported | [1.01](/filings/0000033185-25-000042.md) | [1.32](/filings/0000033185-25-000054.md) | [1.14](/filings/0000033185-25-000064.md) | not reported | [1.07](/filings/0000033185-26-000018.md) | [1.54](/filings/0000033185-26-000028.md) | [1.30](/filings/0000033185-26-000044.md) | not reported | [1.43](/filings/0000033185-26-000018.md) | [1.55](/filings/0000033185-26-000028.md) | [1.80](/filings/0000033185-26-000044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000033185-25-000025.md) | [0.2](/filings/0000033185-24-000032.md) | [0.2](/filings/0000033185-24-000049.md) | [0.5](/filings/0000033185-24-000063.md) | [0.2](/filings/0000033185-26-000010.md) | [0.2](/filings/0000033185-25-000042.md) | [0.2](/filings/0000033185-25-000054.md) | [0.2](/filings/0000033185-25-000064.md) | [0.2](/filings/0000033185-26-000044.md) | [0.2](/filings/0000033185-26-000018.md) | [0.2](/filings/0000033185-26-000028.md) | [0.2](/filings/0000033185-26-000044.md) |
| Current assets | $bn | [1.4](/filings/0000033185-25-000025.md) | [1.4](/filings/0000033185-24-000032.md) | [1.4](/filings/0000033185-24-000049.md) | [1.7](/filings/0000033185-24-000063.md) | [1.4](/filings/0000033185-26-000010.md) | [1.5](/filings/0000033185-25-000042.md) | [1.5](/filings/0000033185-25-000054.md) | [1.5](/filings/0000033185-25-000064.md) | [1.4](/filings/0000033185-26-000044.md) | [1.5](/filings/0000033185-26-000018.md) | [1.6](/filings/0000033185-26-000028.md) | [1.6](/filings/0000033185-26-000044.md) |
| Total assets | $bn | [12.3](/filings/0000033185-25-000025.md) | [12.3](/filings/0000033185-24-000032.md) | [12.2](/filings/0000033185-24-000049.md) | [12.3](/filings/0000033185-24-000063.md) | [11.8](/filings/0000033185-26-000010.md) | [11.9](/filings/0000033185-25-000042.md) | [11.9](/filings/0000033185-25-000054.md) | [11.8](/filings/0000033185-25-000064.md) | [11.9](/filings/0000033185-26-000044.md) | [11.9](/filings/0000033185-26-000018.md) | [12.0](/filings/0000033185-26-000028.md) | [11.9](/filings/0000033185-26-000044.md) |
| Current liabilities | $bn | [2.0](/filings/0000033185-25-000025.md) | [2.0](/filings/0000033185-24-000032.md) | [1.8](/filings/0000033185-24-000049.md) | [1.9](/filings/0000033185-24-000063.md) | [1.8](/filings/0000033185-26-000010.md) | [1.7](/filings/0000033185-25-000042.md) | [1.9](/filings/0000033185-25-000054.md) | [2.0](/filings/0000033185-25-000064.md) | [2.3](/filings/0000033185-26-000044.md) | [2.5](/filings/0000033185-26-000018.md) | [2.6](/filings/0000033185-26-000028.md) | [1.5](/filings/0000033185-26-000044.md) |
| Total liabilities | $bn | [7.6](/filings/0000033185-25-000025.md) | [7.5](/filings/0000033185-24-000032.md) | [7.3](/filings/0000033185-24-000049.md) | [7.3](/filings/0000033185-24-000063.md) | [6.8](/filings/0000033185-26-000010.md) | [6.7](/filings/0000033185-25-000042.md) | [6.7](/filings/0000033185-25-000054.md) | [6.8](/filings/0000033185-25-000064.md) | [7.1](/filings/0000033185-26-000044.md) | [7.3](/filings/0000033185-26-000018.md) | [7.5](/filings/0000033185-26-000028.md) | [7.3](/filings/0000033185-26-000044.md) |
| Long-term debt | $bn | [4.7](/filings/0000033185-25-000025.md) | [4.7](/filings/0000033185-24-000032.md) | [4.7](/filings/0000033185-24-000049.md) | [4.7](/filings/0000033185-24-000063.md) | [4.3](/filings/0000033185-26-000010.md) | [4.3](/filings/0000033185-25-000042.md) | [4.1](/filings/0000033185-25-000054.md) | [4.1](/filings/0000033185-25-000064.md) | [4.1](/filings/0000033185-26-000044.md) | [4.1](/filings/0000033185-26-000018.md) | [4.1](/filings/0000033185-26-000028.md) | [5.0](/filings/0000033185-26-000044.md) |
| Current portion of debt | $bn | [1.0](/filings/0000033185-25-000025.md) | [0.9](/filings/0000033185-24-000032.md) | [0.8](/filings/0000033185-24-000049.md) | [0.8](/filings/0000033185-24-000063.md) | [0.7](/filings/0000033185-26-000010.md) | [0.6](/filings/0000033185-25-000042.md) | [0.8](/filings/0000033185-25-000054.md) | [0.8](/filings/0000033185-25-000064.md) | [1.0](/filings/0000033185-26-000044.md) | [1.3](/filings/0000033185-26-000018.md) | [1.4](/filings/0000033185-26-000028.md) | [0.2](/filings/0000033185-26-000044.md) |
| Shareholders' equity | $bn | [4.5](/filings/0000033185-25-000025.md) | [4.6](/filings/0000033185-24-000032.md) | [4.7](/filings/0000033185-24-000049.md) | [4.9](/filings/0000033185-24-000063.md) | [4.8](/filings/0000033185-26-000010.md) | [5.0](/filings/0000033185-25-000042.md) | [5.1](/filings/0000033185-25-000054.md) | [4.9](/filings/0000033185-25-000064.md) | [4.6](/filings/0000033185-26-000044.md) | [4.5](/filings/0000033185-26-000018.md) | [4.4](/filings/0000033185-26-000028.md) | [4.5](/filings/0000033185-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [322 d](/filings/0000033185-26-000010.md) | [253](/filings/0000033185-25-000042.md) | [268 d](/filings/0000033185-25-000054.md) | [480 d](/filings/0000033185-25-000064.md) | [325 d](/filings/0000033185-26-000010.md) | [224](/filings/0000033185-26-000018.md) | [361 d](/filings/0000033185-26-000028.md) | [560 d](/filings/0000033185-26-000044.md) | [471 d](/filings/0000033185-26-000010.md) | [242](/filings/0000033185-26-000018.md) | [340 d](/filings/0000033185-26-000028.md) | [560 d](/filings/0000033185-26-000044.md) |
| Capital expenditure | $m | [146 d](/filings/0000033185-26-000010.md) | [132](/filings/0000033185-25-000042.md) | [137 d](/filings/0000033185-25-000054.md) | [124 d](/filings/0000033185-25-000064.md) | [119 d](/filings/0000033185-26-000010.md) | [107](/filings/0000033185-26-000018.md) | [122 d](/filings/0000033185-26-000028.md) | [122 d](/filings/0000033185-26-000044.md) | [130 d](/filings/0000033185-26-000010.md) | [120](/filings/0000033185-26-000018.md) | [135 d](/filings/0000033185-26-000028.md) | [124 d](/filings/0000033185-26-000044.md) |
| Dividends paid | $m | [48.1 d](/filings/0000033185-26-000010.md) | [48.2](/filings/0000033185-25-000042.md) | [48.2 d](/filings/0000033185-25-000054.md) | [48.4 d](/filings/0000033185-25-000064.md) | [48.4 d](/filings/0000033185-26-000010.md) | [48.5](/filings/0000033185-26-000018.md) | [62.0 d](/filings/0000033185-26-000028.md) | [61.5 d](/filings/0000033185-26-000044.md) | [60.8 d](/filings/0000033185-26-000010.md) | [67.1](/filings/0000033185-26-000018.md) | [66.4 d](/filings/0000033185-26-000028.md) | [65.9 d](/filings/0000033185-26-000044.md) |
| Share repurchases | $m | not reported | not reported | not reported | [0.0 d](/filings/0000033185-25-000064.md) | [0.0 d](/filings/0000033185-26-000010.md) | [0.0](/filings/0000033185-26-000018.md) | [127 d](/filings/0000033185-26-000028.md) | [300 d](/filings/0000033185-26-000044.md) | [500 d](/filings/0000033185-26-000010.md) | [260](/filings/0000033185-26-000018.md) | [300 d](/filings/0000033185-26-000028.md) | [92.0 d](/filings/0000033185-26-000044.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [124](/filings/0000033185-24-000032.md) | [124](/filings/0000033185-24-000049.md) | [124](/filings/0000033185-24-000063.md) | [125](/filings/0000033185-25-000042.md) | [125](/filings/0000033185-25-000054.md) | [125](/filings/0000033185-25-000064.md) | [125](/filings/0000033185-26-000018.md) | [125](/filings/0000033185-26-000028.md) | [124](/filings/0000033185-26-000044.md) | [121](/filings/0000033185-26-000018.md) | [119](/filings/0000033185-26-000028.md) | [118](/filings/0000033185-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 117,017,174 at 2026-10-09, from the cover of the [10-Q filed 2026-10-20](/filings/0000033185-26-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.